Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (71 ops.)
Latest filing published 27 May 2026 for Castle Biosciences INC. Read the official filing
Filing timeline
BuySaleDaniel Bradbury
Insider track record
Disclosed buys
0
Disclosed sells
71
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Daniel Bradbury: trading record in brief
This profile gathers the share dealings of Daniel Bradbury across 4 companies, led by Castle Biosciences Inc, Illumina, Inc. and Intercept Pharmaceuticals, Inc. Over a trading history stretching from 4 January 2016 to 22 May 2026, the count stands at 83 filings.
Every open-market trade on record is a sale: 71 sales worth €6.9M. The amount is not disclosed for 5 filings. Other entries cover 4 share grants and 6 option exercises.
The latest filing, published on 27 May 2026, reports an option exercise in Castle Biosciences Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Daniel Bradbury
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations83 total
13,667 sharesCommon StockSEC:0001628280-26-038476:0
8,673 sharesCommon StockSEC:0001447362-25-000084:0
5,017 shares@ US$28.1731.6% of flowCommon StockSEC:0001447362-25-000016:0
1,530 shares@ US$28.390.5% of flowCommon StockSEC:0001447362-25-000008:0
4,669 shares@ US$30.9511.6% of flowCommon StockSEC:0001447362-24-000190:0
763 shares@ US$34.920.3% of flowCommon StockSEC:0001447362-24-000172:5
375 shares@ US$33.900.1% of flowCommon StockSEC:0001447362-24-000172:2
1,009 shares@ US$35.330.4% of flowCommon StockSEC:0001447362-24-000172:6
287 shares@ US$35.330.1% of flowCommon StockSEC:0001447362-24-000172:8
1,322 shares@ US$33.900.5% of flowCommon StockSEC:0001447362-24-000172:0
375 shares@ US$33.900.1% of flowCommon StockSEC:0001447362-24-000172:1
2,686 shares@ US$34.921.0% of flowCommon StockSEC:0001447362-24-000172:3
763 shares@ US$34.920.3% of flowCommon StockSEC:0001447362-24-000172:4
287 shares@ US$35.330.1% of flowCommon StockSEC:0001447362-24-000172:7
5,017 shares@ US$29.4431.5% of flowCommon StockSEC:0001447362-24-000158:0
5,017 shares@ US$29.0241.5% of flowCommon StockSEC:0001447362-24-000146:0
5,021 shares@ US$26.6471.4% of flowCommon StockSEC:0001447362-24-000135:0
8,636 sharesCommon StockSEC:0001447362-24-000098:0
7,393 shares@ US$24.641.9% of flowCommon StockSEC:0001447362-24-000064:0
761 shares@ US$20.4530.2% of flowCommon StockSEC:0001447362-24-000048:0
2,901 shares@ US$21.450.7% of flowCommon StockSEC:0001447362-24-000037:0
5,294 shares@ US$20.441.1% of flowCommon StockSEC:0001447362-24-000019:0
658 shares@ US$23.200.2% of flowCommon StockSEC:0001447362-24-000012:0
2,751 shares@ US$22.740.7% of flowCommon StockSEC:0001447362-24-000010:0
5,776 shares@ US$20.401.2% of flowCommon StockSEC:0001447362-24-000008:0
25 of 83 declarations
